High Conviction early stage investor in frontier tech from Baltic Sea Region.
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 12.01.2026 | Avenue Bio... | avenuebiosciences.com | $8.2M | United Sta... |
| 24.10.2025 | VitVio | vitvio.com | $10M | United Sta... |
Mentions in press and media 10
| Date | Title | Description |
| 12.01.2026 | Avenue Biosciences raises $5.7M to scale the first platform modulating the secretory pathway for enhanced therapeutic protein manufacturing | Avenue Biosciences raises $5.7M to scale the first platform modulating the secretory pathway for enhanced therapeutic protein manufacturing Mon, Jan 12, 2026 14:45 CET Report this content Funding will be used to scale the first technology f... |
| 24.11.2025 | The eastern frontier is Europe's new critical deeptech engine | Today, Coinvest Capital, the NATO Innovation Fund (NIF), Depo Ventures, BSV Ventures, Balnord, and New North Ventures — six VC funds actively investing in dual-use and defence — together with market-intelligence platform Dealroom, unveil th... |
| 10.11.2025 | +++ Cargovibe +++ McMakler +++ Bitpanda +++ Balnord +++ Transformation NOW! +++ | Was gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Montag, 10. November). #STARTUPLAND: SAVE THE DATE The next unicorn? You’ll meet it at STARTUPLAND +++ Du ha... |
| 07.11.2025 | Balnord Fund I Surpasses Target, Powers Europe's DeepTech Future | Balnord, a Luxembourg-based early-stage investor, has exceeded its €70M fundraising target for Balnord Fund I. It is poised for a €100M final close by mid-2026. The fund focuses on frontier and dual-use DeepTech in the Baltic Sea Region, fu... |
| 07.11.2025 | Balnord Exceeds Target for €70M Early-stage Fund, Plans €100M Final Close by 2026 | Europe ~ Company: Balnord, a Luxembourg-based early-stage investor focused on the Baltic Sea Region, has announced that it has surpassed its initial €70 million fundraising target, with commitments on track to reach €100 million by mid-2026... |
| 07.11.2025 | Balnord closes €70 million first round to back frontier and dual-use tech across the Baltic Sea Region | Balnord, a Luxembourg-based early stage investor for the Baltic Sea Region, has announced this morning that it has oversubscribed its €70 million fund target and is well on its way to achieving a final close of €100 million by mid-2026. LPs... |
| 07.11.2025 | Balnord: €70 Million Fund Launched To Advance Frontier And Dual Use Technology Across The Baltic Sea Region | Balnord, an early-stage investor focused on companies in the Baltic Sea region, announced that its first fund has oversubscribed its initial €70 million target and is now moving toward a planned final close of €100 million by mid-2026. The ... |
| 07.11.2025 | Balnord unveils €70M fund for frontier and dual-use tech across the Baltic Sea Region | Balnord, an early-stage investor focused on the Baltic Sea region, announced it has exceeded its €70 million fund target and is on track for a final close of €100 million by mid-2026. The firm targets companies advancing Europe’s technologi... |
| 25.10.2025 | AI Innovator VitVio Closes $8M Seed Round for OR Optimization | Boston-based VitVio, an AI pioneer, closed an $8M seed funding round. This brings total funding to $10M. VitVio’s platform transforms hospital operating rooms. It autonomously coordinates surgical teams and flags procedural delays. Real-tim... |
| 23.10.2025 | AI Startup VitVio Raises $8M to Autonomously Optimize Hospital Operating Rooms | What You Should Know: – VitVio, an AI-powered platform designed to autonomously coordinate surgical staff and flag procedural delays secures $8M in seed funding round led by Bek Ventures and joined by LDV Capital, Balnord. – The funding bri... |